MALT lymphoma historical perspective: Difference between revisions
Jump to navigation
Jump to search
Mahshid |
Ahmed Younes (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{MALT lymphoma}} | {{MALT lymphoma}} | ||
{{CMG}}{{AE}}{{SR}} | {{CMG}}{{AE}}{{SR}}, {{AY}} | ||
==Overview== | ==Overview== | ||
Revision as of 19:07, 18 December 2017
|
MALT lymphoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
MALT lymphoma historical perspective On the Web |
|
American Roentgen Ray Society Images of MALT lymphoma historical perspective |
|
Risk calculators and risk factors for MALT lymphoma historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2], Ahmed Younes M.B.B.CH [3]
Overview
MALT lymphoma was first described by Isaacson and Wright in 1983.[1]
Historical Perspective
- MALT lymphoma was first described by Isaacson and Wright in 1983.[1]
- Isaacson and Wright discovered that primary low-grade gastric B cell lymphomas and immunoproliferative small intestinal disease had more histological features in common with those of mucosa associated lymphoid tissue than with peripheral lymph nodes.
- Extranodal low-grade lymphomas arising at other mucosal organs, including the salivary gland, lung, and thyroid, showed similar histological and clinical features establishing the term “MALT lymphoma”.